Nicotine treatment decreases food intake and body weight via a leptin-independent pathway in Psammomys obesus.
It has been reported previously that leptin may be involved in nicotine's ability to reduce body weight. Our aim was to investigate whether the anorexic action of nicotine is related to the actions of leptin by utilizing lean leptin-sensitive and obese leptin-resistant Psammomys obesus. Lean and obese P. obesus were assigned to receive nicotine sulphate at 6, 9 or 12 mg/day or saline (control) for 9 days (n = 6-10 in each group), administered using mini-osmotic pumps. Food intake, body weight, plasma leptin concentrations, plasma insulin and blood glucose were measured at baseline and throughout the study period. Nicotine treatment reduced food intake by up to 40% in lean and obese P. obesus. Plasma leptin levels fell significantly only in lean nicotine-treated animals, whereas no changes were observed in obese nicotine-treated animals. However, both lean and obese nicotine-treated animals had similar reductions in body weight. Our results show that nicotine has dramatic effects on food intake and body weight, however, these changes appear to be independent of the leptin signalling pathway.
Sanigorski
A
A
Metabolic Research Unit, School of Health Sciences, Deakin University, Waurn Ponds, Victoria, Australia. andrewjs@deakin.edu.au
Fahey
R
R
Cameron-Smith
D
D
Collier
G R
GR
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects*; D004435:Eating / Q000187:drug effects*; D005260:Female; D005731:Ganglionic Stimulants / Q000627:therapeutic use*; D005849:Gerbillinae / Q000378:metabolism; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000378:metabolism*; D008297:Male; D009538:Nicotine / Q000627:therapeutic use*
D001786:Blood Glucose; D005731:Ganglionic Stimulants; D007328:Insulin; D020738:Leptin; D009538:Nicotine